Under the spotlight, Guorui is steadily advancing.
Release time:
2023-01-19 16:51
Keywords:
Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. (hereinafter referred to as "Guorui Yinuo") has, since... 2021 Year 07 Moon 09 The product has received a drug approval from the National Medical Products Administration. GLP Since the approval was granted, we have cumulatively received coverage from media outlets including Shaanxi Radio and Television Media Group, Shaanxi TV, Tencent’s Shaanxi Channel, the Xixian Channel of Shaanxi Net, Xi’an News Network, and the Digital Newspaper Platform of the International Business Daily. 20 The repeated reports have drawn widespread attention from governments at all levels and the general public.
The development of enterprises requires their own hard work and dedication, but it also cannot do without the support and assistance from governments at all levels. Currently, Guo Rui Yinuo is steadily carrying out its work under the guidance of the Shaanxi Provincial Department of Science and Technology. “Provincial Key R&D Program Project” and the Xi'an Science and Technology Bureau’s “Qin Chuang Yuan Achievement Transformation Accelerator Project,” and actively apply for pharmaceutical-related projects. GLP Expansion of qualifications across all areas of safety assessment.
Related News
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681